Medical Technology – Issue 6

9 March 2018 (Last Updated March 9th, 2018 16:19)

In this issue: A wireless charging breakthrough for implant treatments, molecular imaging for drug testing, gaining insights from data compliance, and all the latest comment and analysis from GlobalData’s healthcare experts.

Medical Technology – Issue 6

Medical Technology now available on all devices! Read it here for free in the web browser of your computer, tablet or smartphone.

Cambridge Consultants has developed a new wireless charging system for implants which promises flexible and reliable power transfer without precise alignment with the implant, and regardless of the size and body shape of the patient. We find out how this technology could open up new possibilities for implant-based treatments.

Also in this issue, we speak to the UK’s National Measurement Institute about its new 3D OrbiSIMS molecular imaging instrument, which was developed in collaboration with GSK and aims to help determine drug failures earlier in the trial process.

Plus, we hear from AMPLEXOR how advanced data management practices can help life science companies meet stringent new regulations for product information, while also gaining business value by automating data processes.

As always, we also round up the latest news from the medical device industry, and get comment and analysis from GlobalData’s healthcare analysts on market dynamics, product innovation, and regional developments.

In this issue

Spend Wisely: Monetisation Planning in the Healthcare Industry

Investing into the healthcare industry is always a gamble. Government regulations and scientific limitations are two of many factors that not only influence, but dictate the success or failures of a company in the healthcare industry. Nevertheless, venture capital investors made a significant impact in providing financing options for healthcare companies from 2004 to 2012.

Read more.

The Effect of Value-Based Care on the US Medical Devices Industry

On 9 January, the US Centers for Medicare and Medicaid Services (CMS) announced a new payment model, Bundled Payments for Care Improvement (BPCI) Advanced, to provide higher quality and more coordinated care at a lower cost to Medicare for both inpatient and outpatient care.

Read more.

In Vitro Diagnostics: We’ve Got a Test for That

The in vitro diagnostic (IVD) testing market is one of the fastest-growing segments within the medtech industry. As the demand for IVD testing grows, manufacturers are frantically trying to innovate to carve out market share for themselves.

Read more.

Robotic Surgery Markets are Growing Faster than Humans can Handle

With the development of increasingly advanced AI, even high-level surgeons may find themselves replaced by robots as AI exceeds human abilities. The robotic surgery market has been booming globally, despite a lag in the number of surgeons qualified to operate devices like the Da Vinci Surgical System. However, the advent of AI might eliminate this problem altogether as AI overtakes the need to train new surgeons at all.

Read more.

Mitral Valve Repair: The Next Frontier

Heart valve repair and replacement is one of the most innovative and exciting areas in the cardiac devices market. Competitors are constantly fighting to be the first to market with new and innovative technologies. We explore how the sector is evolving.

Read more.

Medtronic to Challenge Penumbra with New Aspiration Receiver

On 16 January 2018, Medtronic announced the FDA approval for its Riptide Aspiration System, completely changing the competitive landscape in neurovascular thrombectomy. We examine how this could change the market.

Read more.

New Patch Aims to Convert Energy-Storing Fats into Energy-Burning Fats

A novel obesity treatment that uses a skin patch to reduce fats around the stomach is demonstrating effectiveness in research facility trials. We find out more.

Read more.

A Breakthrough in Wireless Charging for Implants

A new wireless charging system can power implants efficiently no matter where they are or how they are positioned in the body. Elly Earls meets one of its inventors to find out how it works.

Read more.

Molecular Imaging: Nipping Drug Failure in the Bud

The UK’s National Measurement Institute recently launched the 3D OrbiSIMS, an innovative molecular imaging instrument that could help determine drug failures earlier in the development process. Abi Millar investigates how the tool might improve attrition rates.

Read more.

Gaining Value from Data-Compliance with Master Data Management 2.0

Unless life sciences firms can exploit their product data compliance efforts to transform everyday operational processes, they will limit the return on their investment as they prepare for new requirements. AMPLEXOR’s Siniša Belina explains how a new approach to managing data could help.

Read more.

Next issue preview

 The UK’s new National Centre for Healthcare Photonics, part of the Centre for Process Innovation, is due to open this year. Its work will focus on developing novel technologies for imaging, diagnostics and therapy, as well as offering an open-access workspace for industry collaborations. We speak to the Centre for Process Innovation to find out what the new photonics centre will offer to the UK’s medical technology community.

We also look into concerns raised by the Association of British Healthcare Industries over the future of healthcare exports to the EU, which has been identified as a major target for growth, and find out what it will take to facilitate smooth trade of medical products in a post-Brexit future.

Plus, we speak to ApoQlar about its Virtual Surgery Intelligence, a software tool that creates mixed reality 3D models from MRI and CT scans to help surgeons prepare for surgical procedures, take a look at the latest personal technologies available for medical practitioners, and find out how healthcare providers can prepare for the increasing digitalisation of patient care.

As always, we also get the latest comment and analysis from GlboalData’s healthcare analysts on market dynamics, product innovation, regional developments and regulatory issues.